CASIF (CASI Pharmaceuticals) EV-to-FCF: (As of Jun. 26, 2026)

CASI Pharmaceuticals  (OTCPK:CASIF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

CASI Pharmaceuticals's PE Ratio (TTM) for today is calculated as:

CASI Pharmaceuticals's share price for today is $0.13.
CASI Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.580.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

CASI Pharmaceuticals EV-to-FCF Related Terms

The historical data trend for CASI Pharmaceuticals's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CASI Pharmaceuticals EV-to-FCF Chart

CASI Pharmaceuticals Annual Data
	Trend	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24	Dec25
EV-to-FCF		Get a 7-Day Free Trial					-2.10	0.13	-3.88	-1.69	-1.89

CASI Pharmaceuticals Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
EV-to-FCF	Get a 7-Day Free Trial															-1.69	0.00	0.00	0.00	-1.89

CASIF vs OGEN, VBIO, JAGX: EV-to-FCF Comparison

For the Biotechnology subindustry, CASI Pharmaceuticals's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CASI Pharmaceuticals EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CASI Pharmaceuticals's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where CASI Pharmaceuticals's EV-to-FCF falls into.

CASI Pharmaceuticals EV-to-FCF Calculation

CASI Pharmaceuticals's EV-to-FCF for today is calculated as:

CASI Pharmaceuticals's current Enterprise Value is $24.53 Mil.
CASI Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CASI Pharmaceuticals Business Description